Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke

We present the theoretical background and pathophysiologic mechanisms, animal and human studies of intranasal insulin and IGF-1, and the safety and feasibility of intranasal route for medication administration to the CNS.

http://link.springer.com/10.1007/s12975-015-0409-7

Source: Translational Stroke Research - June 4, 2015 Category: Neurology Source Type: research